The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Nifty may attempt a rally to 5,400-odd levels
Metals, Healthcare, Consumer Durables indices top gainers among sectoral indices on BSE
BSE Metal, Healthcare and Auto indices have surged by almost 1% each
Jindal Steel top Sensex loser
Global cues weak
RIL, Infosys and ICICI Bank lead gains
The stock has outperformed the market, rising 22% post Q1 earnings as compared to 4.7% gain in benchmark Sensex since July 23.
Roche accuses Cipla of infringing its patent on cancer drug Tarceva, which Cipla sells under the brand name Erlocip.
Department of Telecommunications has prepared a revival plan of Rs 4,156.79 crore for the state-owned telecom equipment company
With the latest approval, Aurobindo now has a total of 158 ANDA approvals from the US drug regulator
The stock of pharmaceutical company has rallied 14% in past four trading sessions as compared to1.68% gain in benchmark Sensex
For the fiscal year ended March 31, 2012, Godrej Hershey Limited had net sales of Rs 386 crore and losses of Rs 74 crore
The IMG on coal block allocation will submit its report to Coal Ministry of India on Monday
The board of Peter England Fashions also approved the scheme of arrangement for the demerger of ?Pantaloons Format? business
The stock outperformed the market by appreciating 57% after the company announced the amalgamation of Henkel India on June 13, 2012
The BSE is holding the trading session to test its disaster recovery software
The annual sales of Amlodipine Besylate and Benazepril Hydrochloride capsules is approximately $500 million for the twelve months ending March 2012
The board of directors of the company will be held on today, to consider the proposal for sale of Max Speciality Films division
NSE F&O turnover above Rs 100,000 cr
The board has recommended a dividend @ Rs 28/- per equity share for the financial year ended March 31, 2012.